These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 8370239

  • 21. Effects of the neuropeptide Y Y2 receptor antagonist BIIE0246 on sympathetic transmitter release in the pig in vivo.
    Malmström RE, Lundberg JN, Weitzberg E.
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):106-11. PubMed ID: 11819028
    [Abstract] [Full Text] [Related]

  • 22. Sympathetic stimulation-evoked overflow of norepinephrine and neuropeptide Y from the heart.
    Warner MR, Senanayake PD, Ferrario CM, Levy MN.
    Circ Res; 1991 Aug; 69(2):455-65. PubMed ID: 1776971
    [Abstract] [Full Text] [Related]

  • 23. Changes in the levels of neuropeptide Y-LI in the external jugular vein in connection with vasoconstriction following subarachnoid haemorrhage in man. Involvement of sympathetic neuropeptide Y in cerebral vasospasm.
    Juul R, Edvinsson L, Fredriksen TA, Ekman R, Brubakk AO, Gisvold SE.
    Acta Neurochir (Wien); 1990 Aug; 107(3-4):75-81. PubMed ID: 2077856
    [Abstract] [Full Text] [Related]

  • 24. Motilin- and neuropeptide Y-like immunoreactivity in a psychophysiological stress experiment on patients with functional dyspepsia.
    Jonsson BH, Hellström PM.
    Integr Physiol Behav Sci; 2000 Aug; 35(4):256-65. PubMed ID: 11330489
    [Abstract] [Full Text] [Related]

  • 25. Sympatho-adrenal secretion in humans: factors governing catecholamine and storage vesicle peptide co-release.
    Takiyyuddin MA, Brown MR, Dinh TQ, Cervenka JH, Braun SD, Parmer RJ, Kennedy B, O'Connor DT.
    J Auton Pharmacol; 1994 Jun; 14(3):187-200. PubMed ID: 7929473
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Neurohormonal activation in patients with acute myocardial infarction or chronic congestive heart failure. With special reference to treatment with angiotensin converting enzyme inhibitors.
    Sigurdsson A.
    Blood Press Suppl; 1995 Jun; 1():1-45. PubMed ID: 7599749
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Neuropeptide Y-like immunoreactivity and hypertension.
    Erlinge D, Ekman R, Thulin T, Edvinsson L.
    J Hypertens; 1992 Oct; 10(10):1221-5. PubMed ID: 1335004
    [Abstract] [Full Text] [Related]

  • 30. Increases in plasma neuropeptide Y concentrations during sympathetic activation in man.
    Morris MJ, Russell AE, Kapoor V, Cain MD, Elliott JM, West MJ, Wing LM, Chalmers JP.
    J Auton Nerv Syst; 1986 Oct; 17(2):143-9. PubMed ID: 3782722
    [Abstract] [Full Text] [Related]

  • 31. Evidence for co-transmitter role of neuropeptide Y in the pig spleen.
    Lundberg JM, Rudehill A, Sollevi A, Hamberger B.
    Br J Pharmacol; 1989 Mar; 96(3):675-87. PubMed ID: 2566349
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Sympathetic vascular control of the pig nasal mucosa (III): Co-release of noradrenaline and neuropeptide Y.
    Lacroix JS, Stjärne P, Anggärd A, Lundberg JM.
    Acta Physiol Scand; 1989 Jan; 135(1):17-28. PubMed ID: 2911948
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Haemodynamic, neuroendocrine and metabolic correlates of circulating cytokine concentrations in congestive heart failure.
    Lommi J, Pulkki K, Koskinen P, Näveri H, Leinonen H, Härkönen M, Kupari M.
    Eur Heart J; 1997 Oct; 18(10):1620-5. PubMed ID: 9347273
    [Abstract] [Full Text] [Related]

  • 37. Neuropeptide Y, left ventricular mass and function in patients with end stage renal disease.
    Zoccali C, Mallamaci F, Tripepi G, Benedetto FA, Parlongo S, Cutrupi S, Bonanno G, Rapisarda F, Fatuzzo P, Seminara G, Cataliotti A, Malatino LS.
    J Hypertens; 2003 Jul; 21(7):1355-62. PubMed ID: 12817184
    [Abstract] [Full Text] [Related]

  • 38. Effects of vinblastine on neuropeptide Y levels in the sympathoadrenal system, bone marrow and thrombocytes of the rat.
    Hemsén A, Pernow J, Millberg BI, Lundberg JM.
    Agents Actions; 1991 Nov; 34(3-4):429-38. PubMed ID: 1810152
    [Abstract] [Full Text] [Related]

  • 39. Neuropeptide Y is elevated in heart failure and is an independent predictor of outcomes.
    McDowell K, Adamson C, Jackson C, Campbell R, Welsh P, Petrie MC, McMurray JJV, Jhund PS, Herring N.
    Eur J Heart Fail; 2024 Jan; 26(1):107-116. PubMed ID: 37937329
    [Abstract] [Full Text] [Related]

  • 40. Release and vasoconstrictor effects of neuropeptide Y in relation to non-adrenergic sympathetic control of renal blood flow in the pig.
    Pernow J, Lundberg JM.
    Acta Physiol Scand; 1989 Aug; 136(4):507-17. PubMed ID: 2571235
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.